Researchers Helena Verkooijen

Helena Verkooijen

Full Professor

Strategic program(s):

Biography

Professor of Evaluation of Image-Guided Treatment, dedicated to improve the life of people with cancer. Committed to full integration of clinical research in routine patient care in order to facilitate undelayed evidence-based implementation of innovations in oncology.
Medical-scientific director of the Imaging Cluster (incorporating the departments of Radiology, Radiotherapy, Nuclear Medicine and Clinical Physics) at the Antoni van Leeuwenhoek hospital. Leader (PI) of several international research consortia and academic industrial partnership, based at UMC Utrecht. Strong background in teaching and development of educational modules at graduate and postgraduate level. Large international academic experience in Europe and Asia. Experienced speaker, moderator, panel member, and member of the supervisory board of the Rotterdam Eye Hospital.
Sharp analytic mind, strong drive and ability to turn ideas into reality. Connector. Passionate about encouraging and facilitating colleagues, team members, and (PhD) students to bring out the best in themselves and each other.

Strategic program(s):

Contact

h.m.verkooijen@umcutrecht.nl

Pure profile

Research groups

Evaluation of imaging and image-guided Interventions

Research aim

The pace of innovation in (AI driven) imaging/image-guided interventions in oncology is high; the window of opportunity for evaluation narrow. We aim to learn from every patient, in order to facilitate evidence-based implementation of innovation.

Go to group

Recent publications

All publications

Hyperbaric Oxygen Therapy and Late Local Toxic Effects in Patients With Irradiated Breast Cancer Dieuwke R Mink van der Molen, Marilot C T Batenburg, Wiesje Maarse, Desiree H J G van den Bongard, Annemiek Doeksen, Marjoleine Y de Lange, Carmen C van der Pol, Daniel J Evers, Corine A Lansdorp, Jacco van der Laan, Peter M van de Ven, Femke van der Leij, Helena M Verkooijen
JAMA Oncology, 2024, vol. 10, p.464-474

Quality of life and clinical outcomes in rectal cancer patients treated on a 1.5T MR-Linac within the MOMENTUM study L. A. Daamen, J. M. Westerhoff, A. M. Couwenberg, P. M. Braam, H. Rütten, M. D. den Hartogh, J. P. Christodouleas, W. A. Hall, H. M. Verkooijen, M. P.W. Intven
Clinical and translational radiation oncology, 2024, vol. 45

Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy Renée Bultijnck, Mieke Van Hemelrijck, Valérie Fonteyne, Lorenzo Livi, Barbara Alicja Jereczek-Fossa, Hossein Hemmatazad, Michael Mayinger, Heike Peulen, Luc Verbeke, Sara Ramella, Pablo Castro, Pelagia Tsoutsou, Karin Stellamans, Adnan Shaukat, Miha Orazem, Paul Jeene, Pètra Braam, Helena Verkooijen, Inga Malin Simek, Filippo Alongi, Enrico Clementel, Catherine Fortpied, Abigirl Machingura, Felix Boakye Oppong, Matthias Guckenberger, Piet Ost
Clinical and translational radiation oncology, 2024, vol. 45

Stereotactic Body and Conventional Radiotherapy for Painful Bone Metastases Bas J J Bindels, Carole Mercier, Roxanne Gal, Jorrit-Jan Verlaan, Joost J C Verhoeff, Piet Dirix, Piet Ost, Nicolien Kasperts, Yvette M van der Linden, Helena M Verkooijen, Joanne M van der Velden
JAMA network open, 2024, vol. 7, p.1-14

Competing risk analysis of cardiovascular disease risk in breast cancer patients receiving a radiation boost Yvonne Koop, Femke Atsma, Marilot C T Batenburg, Hanneke Meijer, Femke van der Leij, Roxanne Gal, Sanne G M van Velzen, Ivana Išgum, Hester Vermeulen, Angela H E M Maas, Saloua El Messaoudi, Helena M Verkooijen
Cardio-oncology (London, England), 2024, vol. 10

Correction L. A. Daamen, I. W.J.M. van Goor, V. P. Groot, P. C.M. Andel, L. A.A. Brosens, O. R. Busch, G. A. Cirkel, N. Haj Mohammad, H. D. Heerkens, I. H.J.T. de Hingh, F. Hoogwater, H. W.M. van Laarhoven, M. Los, G. J. Meijer, V. E. de Meijer, R. Pande, K. J. Roberts, J. Stoker, M. W.J. Stommel, G. van Tienhoven, R. C. Verdonk, H. M. Verkooijen, F. J. Wessels, J. W. Wilmink, M. G. Besselink, H. C. van Santvoort, M. P.W. Intven, I. Q. Molenaar,
Trials, 2024, vol. 25

External positions

Lid raad van toezicht - Toezicht - BCN / Alexander Monro Ziekenhuis

Lid raad van toezicht - Toezicht - Oogziekenhuis Rotterdam

Lid Commissie Exploratie - Beoordeling wetenschappelijke aanvragen - KWF Kankerbestrijding

bestuurslid - geen - JM Fentener van Vlissingen Fonds

Spreker - ja - Elekta

Lid Wetenschappelijke Adviesraad Landelijk ReferentieCentrum Bevolkingsonderzoek - inhoudelijk - LRCB